Dr. Reddy’s gets CDSCO nod to export 15 drugs to European Union market: Report

08 Aug 2016 Evaluate

Dr. Reddy’s Laboratories, Hyderabad-based pharmaceutical company, has reportedly received an approval from the Central Drug Standard Control Organisation (CDSCO) to export drugs for the European Union market. In an order dated August 5, CDSCO gave its nod, which will allow Dr Reddy’s to export 15 active pharmaceutical ingredients (APIs) to the European Union.

These drugs are used to treat hypertension, pneumonia, bacterial infection, cardiovascular diseases and migraine, among others. The order will enable the company to import these substances for a period of three years, ending June 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1209.45 1.95 (0.16%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×